Opening book details…
About this Medicine article
ATIM-38. PHASE 2 STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF MEDI4736 (DURVALUMAB, DURVA) + BEVACIZUMAB (BEV) IN BEV-NAÏVE PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) by Reardon, David; Kaley, Thomas; Dietrich, Jorg; Clarke, Jennifer; Dunn, Gavin; Lim, Michael; Cloughesy, Tim; Gan, Hui; Park, Andrew; Schwarzenberger, Paul; Ricciardi, Toni; Macri, Mary; Ryan, Aileen; Venhaus, Ralph is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Reardon, David; Kaley, Thomas; Dietrich, Jorg; Clarke, Jennifer; Dunn, Gavin; Lim, Michael; Cloughesy, Tim; Gan, Hui; Park, Andrew; Schwarzenberger, Paul; Ricciardi, Toni; Macri, Mary; Ryan, Aileen; Venhaus, Ralph
- Publisher
- Duke University Press; Oxford University Press; Oxford University Press (OUP) (ISSN 1522-8517)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)